David K. Gaffney
( out of 180 reviews )

David K. Gaffney, MD, PhD, FASTRO, FACR, FABS

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2396
Get Directions

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

David Gaffney, MD, PhD, enjoys treating cancer patients and improving care through clinical trials. He is Executive Vice-Chair and Professor of the Department of Radiation Oncology and holds the J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. He is currently serving as the Interim Senior Director for Clinical Research at the Huntsman Cancer Institute. His main research interests are in clinical trial development, quality of life for gynecologic cancer patients, prognostic markers, and secondary cancers. Dr. Gaffney served as principal investigator for the UG1 Lead Academic Program Site grant that facilitates participation in late phase clinical trials funded by the National Cancer Institute. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.

He serves as a co-Chair for the Gynecologic Cancer Committee for NRG Oncology. He is a past chair of the American Brachytherapy Society, Cervix Committee in the Gyn Cancer InterGroup, and Cervix Cancer Research Network. He served 6 years as a co-Chair for the National Cancer Institute’s Gynecologic Cancer Steering Committee. He enjoys serving as Associate Editor for Gynecologic Oncology and being on the editorial board for the International Journal of Gynecologic Cancer, and Brachytherapy. He recently served on the Board of Directors for the International Gynecologic Cancer Society.

Dr. Gaffney enjoys working with medical students, residents, and junior faculty on a wide variety of projects.

Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in Radiation Oncology at the University of Utah School of Medicine.

Podcast:
Multidisciplinary Conversations with Radiation Oncologist David Gaffney, International Gynecologic Cancer Society (IGCS)

Specialties

Board Certification

American Board of Radiology (Radiation Oncology)

Patient Rating

Patients consistently describe Dr. Gaffney as knowledgeable and up-to-date on cancer research, providing clear treatment options and the information needed to make informed decisions. Reviewers emphasize his compassionate, personable bedside manner—he listens, explains treatments thoroughly, and includes patients in care planning. Many note that they trust him, feel cared for, and appreciate his attentive communication.

Generated via Patient Reviews

5.0 /5
( out of 180 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Dec 18, 2025
HUNTSMAN CANCER CENTER

Dr. Gaffney is awesome. Very personable and he knows his stuff!

Oct 07, 2025
SUGAR HOUSE HEALTH CENTER

He is a very personable Dr, always concerned about how I feel and or if I have any concerns.

Oct 05, 2025
SUGAR HOUSE HEALTH CENTER

Dr Gaffney is a fantastic doctor. He was up to date on the latest cancer research and provided me with the best treatment options for my cancer. He took time to answer all of my questions and seemed to really care about helping me get well. I highly recommend him.

Aug 21, 2025
HUNTSMAN CANCER CENTER

Dr. Gaffney was so kind and caring. He included me in the conversation when "my team" was discussing possible treatments. I felt I could talk about my apprehensions.... and how my age (of 80) would "play in the plan" for recovery. I was so impressed! I'm actually not afraid now ... I'm looking forward to being "part of the team".

Jul 03, 2025
HUNTSMAN CANCER CENTER

This physician is not only expert in his field, but excellent bedside manner, very likable.

Jun 28, 2025
SUGAR HOUSE HEALTH CENTER

Dr. Gaffney provided me with the information I needed to make a decision about treatment. I feel confident that I will get excellent care as a result of my visit.

Sep 23, 2024
HUNTSMAN CANCER CENTER

He is a wonderful human and cares about his patients.

Sep 22, 2024
SUGAR HOUSE HEALTH CENTER

Dr Gaffney is professional, very knowledgable, friendly and kind. I trust him completely.

Sep 20, 2024
HUNTSMAN CANCER CENTER

Trust in him, expertise, compassionate, he listens and takes the time to explain.

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

David Gaffney, MD, PhD, enjoys treating cancer patients and improving care through clinical trials. He is Executive Vice-Chair and Professor of the Department of Radiation Oncology and holds the J Robert and Ann K Stewart Endowed Professorship at the Huntsman Cancer Institute. He is currently serving as the Interim Senior Director for Clinical Research at the Huntsman Cancer Institute. His main research interests are in clinical trial development, quality of life for gynecologic cancer patients, prognostic markers, and secondary cancers. Dr. Gaffney served as principal investigator for the UG1 Lead Academic Program Site grant that facilitates participation in late phase clinical trials funded by the National Cancer Institute. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma.

He serves as a co-Chair for the Gynecologic Cancer Committee for NRG Oncology. He is a past chair of the American Brachytherapy Society, Cervix Committee in the Gyn Cancer InterGroup, and Cervix Cancer Research Network. He served 6 years as a co-Chair for the National Cancer Institute’s Gynecologic Cancer Steering Committee. He enjoys serving as Associate Editor for Gynecologic Oncology and being on the editorial board for the International Journal of Gynecologic Cancer, and Brachytherapy. He recently served on the Board of Directors for the International Gynecologic Cancer Society.

Dr. Gaffney enjoys working with medical students, residents, and junior faculty on a wide variety of projects.

Dr. Gaffney received his PhD in biochemistry from the Medical College of Wisconsin in 1990 and his MD from the same institution in 1992. He completed an internship at LDS Hospital in Salt Lake City, Utah, and a residency in Radiation Oncology at the University of Utah School of Medicine.

Podcast:
Multidisciplinary Conversations with Radiation Oncologist David Gaffney, International Gynecologic Cancer Society (IGCS)

Board Certification and Academic Information

Academic Departments Radiation Oncology -Professor
Board Certification
American Board of Radiology (Radiation Oncology)

Selected Publications

Journal Article

  1. Ryu SY, Nam BH, Kim MH, Jang WI, Sitathanee C, Linh TD, Lee KH, Lee WM, Kim ET, Kang SB, Kim JH, Park JY, Lee KB, Cho CH, Lou H, Kim YH, Kim YT, Lee YH, Wu X, Kim JW, Park SI, Jeon S, Thinh DH, Kry SF, Gaffney D, Small W, Wilailak S (2026). A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) study. ESMO Open, 11(4), 106102.
  2. Weil CR, Brower J, Small W Jr, Gaffney DK, Klopp AH (2025). Immunotherapy in the upfront definitive management of locally advanced cervical cancer: An evolving treatment paradigm. Pract Radiat Oncol.
  3. Abu-Rustum NR, Campos SM, Amarnath S, Arend R, Barber E, Bradley K, Brooks R, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Howitt BE, Landrum L, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Nieto K, Nwachukwu C, Podoll M, Rodabaugh K, Salani R, Schorge J, Schuetze S, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian N, Sambandam V (2025). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025. J Natl Compr Canc Netw, 23(8), 284-291.
  4. Chino J, Erickson B, Gaffney D, Hsu IC, Kamrava M, Kim Y, Niedermayr TR, Roumeliotis M, Rownd J, Todor D, Viswanathan A, Kidd EA (2025). The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy, 24(4), 463-478.
  5. Martin T, Nelson G, Gaffney D, Dial C, Szegedi M, Rassiah P (2025). Modified total skin electron treatment for a paraplegic patient. J Appl Clin Med Phys, 26(7), e70162.
  6. DeCesaris C, Bedell S, Gaffney D, Suneja G, Burt L, Brower J (2025). Identification and Management of Late toxicities after Radiotherapy for Vulvar Cancer. Pract Radiat Oncol.
  7. Corrigan KL, Paulus R, Klopp AH, Wenzel LB, Yeung AR, Thompson JS, Doncals DE, Kundapur V, Wiggers NH, Mohan DS, Ghamande SA, Westin SN, Schnarr KL, Haas ML, Gaffney DK, Waggoner SE, Vanderwall PJ, Jastaniyah NT, Pugh SL, Kachnic LA (2025). Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203. JCO Oncol Adv, 2(1), e2400088.
  8. Poppe MM, Boucher K, Gaffney DK, Brownson KE, Smith G, Howell JN, Ticona FF, Kim J, Burt L, Cannon D, Kokeny K (2025). NOVEMBER, A Phase 2 Trial of a 9-Day Course of Whole Breast Radiation Therapy With a Simultaneous Lumpectomy Boost for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys, 123(1), 141-149.
  9. Cruttenden J, Grant J, Evans J, Cannon G, Gaffney DK, Poppe M, Burt LM, Avizonis V, Boothe D (2025). Impact of Consensus Guidelines, Clinical Trials, and COVID-19 on Fractionation Practices for Node-negative Intact Breast Cancer. Am J Clin Oncol, 48(5), 222-229.
  10. Howell JN, Mark B, Wada DA, Bowling M, Wei M, Lloyd SL, Gaffney DK, Maity A, LaRiviere MJ, Rule WG, Grant JD, Deshmukh V, Newman M, Date A, Hashibe M, Tao R (2024). Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes. Cancer Med, 14(5), e70577.
  11. Suneja G, Huang YJ, Boucher KM, Braun E, Burt LM, DeCesaris C, Grant JD, Harkenrider MM, Jhingran A, Kidd EA, Klopp AH, Lin LL, Small W, Gaffney D (2024). Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial. JCO Oncol Adv, 1(1).
  12. Cruttenden J, Weil C, Byer D, Burt L, Suneja G, Gaffney D, DeCesaris C (2024). Patterns of Care in Adjuvant Radiation Therapy for Stage II Endometrioid Endometrial Adenocarcinoma: A National Cancer Database Analysis. Adv Radiat Oncol, 10(2), 101698.
  13. Fields EC, Bosch WR, Albuquerque KV, Bhatia R, Chino J, Dyer B, Erickson B, Fabian D, Gaffney D, Glaser S, Han K, Hathout L, Hsu IC, Jegadeesh N, Kahn J, Kidd E, Klopp A, Leung E, Lin L, Ludwig M, Ma T, Mell L, Mayadev J, Petersen I, Portelance L, Rash D, Taunk N, Viswanathan A, Wolfson A, Yashar C, Yeung A, Yoshida E, Fisher CM (2024). Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update. Pract Radiat Oncol, 15(2), 171-179.
  14. DeCesaris C, Bedell S, Kelley K, Gaffney D, Suneja G, Burt L, Jarboe E, Brower J (2024). Use of Radiation Therapy in the Management of Vulvar Cancers-Identification and Management of Acute and Late Toxicities. Pract Radiat Oncol, 15(1), e57-e62.
  15. DeCesaris C, Wilson T, Kim J, Burt L, Grant J, Harkenrider MM, Huang J, Jhingran A, Kidd E, Konski A, Lin L, Small W Jr, Suneja G, Gaffney D (2024). Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol, 14(6), e500-e506.
  16. Kasera S, Weil CR, Wada D, Bowling M, Hu B, Gaffney DK, Maity A, Tao R (2024). Ultra-low dose radiation therapy for primary cutaneous indolent B-cell lymphomas. JEADV Clin Pract, 3(4), 1190-1194.
  17. Creutzberg CL, Kim JW, Eminowicz G, Allanson E, Eberst L, Kim SI, Nout RA, Park JY, Lorusso D, Mileshkin L, Ottevanger PB, Brand A, Mezzanzanica D, Oza A, Gebski V, Pothuri B, Batley T, Gordon C, Mitra T, White H, Howitt B, Matias-Guiu X, Ray-Coquard I, Gaffney D, Small W Jr, Miller A, Concin N, Powell MA, Stuart G, Bookman MA, participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research (2024). Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Lancet Oncol, 25(9), e420-e431.
  18. Burt L, Jarboe E, Gaffney D, Suneja G, DeCesaris C, Bedell S, Brower J (2024). Vulvar Cancer: Histopathologic Considerations and Nuances to Management: Vulvar cancer considerations and nuances. Pract Radiat Oncol, 15(1), 86-92.
  19. Gaffney D, Suneja G, Weil C, Creutzberg C (2024). FIGO Endometrial 2023 is better for radiation oncology patients. Pract Radiat Oncol.
  20. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM (2024). Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. Eur J Cancer, 201, 113913.
  21. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R II, Glaser S, Holmes J, Howitt BE, Kendra K, Lea J, Lee N, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian N, Espinosa S (2024). Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 22(2), 117-135.
  22. Roach E, Hutten R, Johnson S, Suneja G, Tward J, Petereit D, Gaffney D (2024). The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy. Brachytherapy, 23(3), 360-367.
  23. Harari CM, Brower JV, Gaffney DK, Bradley KA (2024). Navigating the Complexities of Lymph Node Management in Vulvar Cancer: Insights and Perspectives. Pract Radiat Oncol.
  24. Zhao H, Sarkar V, St James S, Paxton A, Su FF, Price RG, Dial C, Poppe M, Gaffney D, Salter B (2024). Verification of surface-guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT-on-rails and kV-2D alignment. J Appl Clin Med Phys, 25(2), e14263.
  25. Ufkes NA, Tao R, Halwani AS, Miles R, Cipriano SD, Bowling M, Florell S, Gaffney D, Wada DA (2024). Clinical spectrum of indolent mycosis fungoides with a gamma-delta (γδ) phenotype: a single institution review including therapy and outcomes. JEADV Clin Pract.
  26. Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S (2023). NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw, 21(12), 1224-1233.
  27. Ermann DA, Vardell VA, Shah H, Fitzgerald L, Tao R, Gaffney DK, Stephens DM, Hu B (2023). Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy. Clin Lymphoma Myeloma Leuk, 24(2), 94-104.e6.
  28. Huang YJ, DeCesaris CM, Sarkar V, Zhao H, Kunz J, Nelson G, Li X, Suneja G, Burt LM, Gaffney DK (2023). Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy, 23(1), 25-34.
  29. Hutten RJ, Weil CR, King AJ, Barney B, Bylund CL, Fagerlin A, Gaffney DK, Gill D, Scherer L, Suneja G, Tward JD, Warner EL, Werner TL, Whipple G, Evans J, Johnson SB (2023). Multi-Institutional Analysis of Cancer Patient Exposure, Perceptions, and Trust in Information Sources Regarding Complementary and Alternative Medicine. JCO Oncol Pract, 19(11), OP2300179.
  30. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N, Endometrial Cancer Staging Subcommittee FIGO Womens Cancer Committee (2023). FIGO staging of endometrial cancer: 2023. J Gynecol Oncol, 34(5), e85.
  31. Lee SS, Weil CR, Boyd LR, DeCesaris C, Gaffney D, Suneja G (2023). Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258. Int J Gynecol Cancer, 33(9), 1408-1418.
  32. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N, Endometrial Cancer Staging Subcommittee FIGO Womens Cancer Committee (2023). FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet.
  33. Mileshkin LR, Moore KN, Barnes EH, Gebski V, Narayan K, King MT, Bradshaw N, Lee YC, Diamante K, Fyles AW, Small W Jr, Gaffney DK, Khaw P, Brooks S, Thompson JS, Huh WK, Mathews CA, Buck M, Suder A, Lad TE, Barani IJ, Holschneider CH, Van Dyk S, Quinn M, Rischin D, Monk BJ, Stockler MR (2023). Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial. Lancet Oncol, 24(5), 468-482.
  34. Kunz JN, Huang YJ, Casper AC, Suneja G, Burt LM, Jhingran A, Joyner MM, Harkenrider MM, Small W Jr, Grant JD, Kidd EA, Boucher K, Gaffney DK (2023). Dosimetric Evaluation of OARs from SAVE Protocol. Int J Radiat Oncol Biol Phys.
  35. Kunzman J, Hutten R, Kelley K, Harris K, Gaffney DK, DeCesaris C, Suneja G, Burt LM (2023). Treatment patterns for leiomyosarcomas, endometrial stromal sarcomas and adenosarcomas: a national cancer database study. European Journal of Gynecological Oncology, 44(2), 25-31.
  36. Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S (2023). Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 21(2), 181-209.
  37. Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney DK (2022). Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality. Cancer Med, 12(3), 2624-2636.
  38. Chang CP, Wilson CM, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Fraser A, Smith K, Date A, Stanford JB, Gaffney D, Mooney K, Hashibe M (2022). Sexual dysfunction among gynecologic cancer survivors in a population-based cohort study. Support Care Cancer, 31(1), 51.
  39. Sherertz T, Jhingran A, Biagioli M, Gaffney D, Elshaikh M, Coleman RL, Harkenrider M, Kidd EA, Jolly S, Yashar C, Portelance L, Wahl A, Venkatesan A, Li L, Small W Jr, American Radium Society (2022). Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. Int J Gynecol Cancer.
  40. Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao R (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leuk Lymphoma, 64(2), 1-8.
  41. Hutten RJ, Fenlon JB, Kessel AC, Straessler KM, Huang YJ, Gaffney DK, Suneja G, Zempolich K, Burt LM (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy, 21(6), 764-768.
  42. Tao R, Chen Y, Kim S, Ocier K, Lloyd S, Poppe MM, Lee CJ, Glenn MJ, Smith KR, Fraser A, Deshmukh V, Newman MG, Snyder J, Rowe KG, Gaffney DK, Haaland B, Hashibe M (2022). Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survival. Cancer, 128(19), 3564-3572.
  43. Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja G (2022). Racial and Ethnic Health Disparities in Delay to Initiation of Intensity-Modulated Radiotherapy. JCO Oncol Pract, 18(10), e1694-e1703.
  44. Weil CR, Parsons MJ, Hutten RJ, Lew FH, Johnson SB, Gaffney DK, Tao R (2022). Patterns of care and outcomes of early stage I-II Hodgkin lymphoma treated with or without radiation therapy. Leuk Lymphoma, 63(12), 1-11.
  45. Rock CB, Chipman JJ, Parsons MW, Weil CR, Hutten RJ, Tao R, Tward JD, Shah HR, Hu B, Stephens DM, Gaffney DK (2022). Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. Adv Radiat Oncol, 7(6), 101035.
  46. Hu S, Baraghoshi D, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Peoples AR, Gaffney D, Hashibe M (2022). Mental health disorders among ovarian cancer survivors in a population-based cohort. Cancer Med, 12(2), 1801-1812.
  47. Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney DK (2022). Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leuk Lymphoma, 63(10), 1-8.
  48. Dood R, Trabert B, Werner TL, Gaffney D, Jarboe E (2022). The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers. Int J Gynecol Cancer, 32(8), 1087-1088.
  49. Hutten RJ, Weil CR, Gaffney DK, Kokeny K, Lloyd S, Rogers CR, Suneja G (2022). Worsening Racial Disparities in Utilization of Intensity Modulated Radiation Therapy. Adv Radiat Oncol, 7(3), 100887.
  50. Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney DK (2022). Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality. Cancer Med.
  51. Hutten RJFenlon JBKessel ACStraessler KMHuang YJGaffney DKSuneja GZempolich KBurt LM (2022). Radical trachelectomy and adjuvant vaginal brachytherapy to preserve fertility in pediatric cervical adenocarcinoma. Brachytherapy, epub ahead of print.
  52. Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241.
  53. Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD (2021). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw, 19(8), 888-895.
  54. Hu Q, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Gren LH, Porucznik C, Stanford JB, Gaffney D, Henry NL, Lopez I, Hashibe M (2021). Disparities in Cardiovascular Disease Risk among Hispanic Breast Cancer Survivors in a Population-Based Cohort. JNCI Cancer Spectr, 5(2).
  55. Holcombe RF, Verschraegen CF, Chapman AE, Gaffney D, Goldberg RM, Mesa RA, Milhem M, Mims M, Mitchell EP, Mulkerin D, Vijayakumar S (2021). Status of the Clinician Investigator in America: An Essential Healthcare Provider Driving Advances in Cancer Care. J Natl Compr Canc Netw, 19(2), 122-125.
  56. Small W Jr, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, Beriwal S, Creutzberg CL, Eifel PJ, Erickson BA, Fyles AW, Hentz CL, Jhingran A, Klopp AH, Kunos CA, Mell LK, Portelance L, Powell ME, Viswanathan AN, Yacoub JH, Yashar CM, Winter KA, Gaffney DK (2020). NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update. Int J Radiat Oncol Biol Phys, 109(2), 413-424.
  57. Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma V, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney DK (2021). Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Glob Oncol, 7, 173-182.

Review

  1. Cun HT, Bedell SM, Kimball J, Gaffney DK, Hasan Y (2025). Radiation therapy for the gynecologic oncologist. [Review]. Gynecol Oncol, 204, 79-90.
  2. Matias-Guiu X, Lax S, Raspollini MR, Palacios J, Zheng W, Liu C, de Brot L, Lordello L, Hardisson D, Gaffney D, Mutch D, Scambia G, Creutzberg CL, Fotopoulou C, Berek JS, Concin N (2024). FIGO 2023 staging for endometrial cancer, when, if it is not now? [Review]. Eur J Cancer, 213, 115115.
  3. Gaffney D, Matias-Guiu X, Mutch D, Scambia G, Creutzberg C, Fotopoulou C, Berek JS, Concin N (2024). 2023 FIGO staging system for endometrial cancer: The evolution of the revolution. [Review]. Gynecol Oncol, 184, 245-253.
  4. Ladbury C, Sueyoshi MH, Brovold NM, Kumar R, Andraos TY, Gogineni E, Kim M, Klopp A, Albuquerque K, Kunos C, Leung E, Mantz C, Biswas T, Beriwal S, Small W Jr, Erickson B, Gaffney D, Lo SS, Viswanathan AN (2023). Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice Review. [Review]. Pract Radiat Oncol.
  5. Ladbury C, Harkenrider M, Taunk N, Fisher C, Mayadev J, Venkat P, Yashar C, Gaffney D, Beriwal S, Glaser S (2023). A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer. [Review]. Brachytherapy.
  6. Sagae S, Toita T, Matsuura M, Saito M, Matsuda T, Sato N, Shimizu A, Endo T, Fujii M, Gaffney DK, Small W Jr (2023). Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. [Review]. Int J Gynecol Cancer.
  7. Griffith T, Nwachukwu C, Albuquerque K, Gaffney D (2022). The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer. [Review]. Brachytherapy, 21(2), 177-185.
  8. Huang YJ, Gaffney D (2022). Brachytherapy: Common pitfalls. [Review]. Int J Gynecol Cancer, 32(3), 352-357.
  9. Parsons MW, Huang YJ, Burt L, Suneja G, Gaffney D (2022). Vaginal cuff brachytherapy for endometrial cancer: A review of major clinical trials with a focus on fractionation. [Review]. Int J Gynecol Cancer, 32(3), 311-315.
  10. McCormack M, Gaffney D, Tan D, Bennet K, Chavez-Blanco A, Plante M (2021). The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries. [Review]. Int J Gynecol Cancer, 31(5), 775-778.

Book Chapter

  1. Renz M, Elkas JC, Gaffney D (2025). Cervical and Vaginal Cancer (Ch. 38). In Berek & Novak's Genecology (17). Wolters Kluwer.

Conference Proceedings

  1. Yeung AR, Deshmukh S, Klopp AH, Gil KM, Wenzel L, Westin SN, Konski AA, Gaffney DK, Small W, Thompson JS, Doncals DE, Cantuaria GHC, DSouza DP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW (2022). Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared with Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial. In Yeung AR|Deshmukh S|Klopp AH|Gil KM|Wenzel L|Westin SN|Konski AA|Gaffney DK|Small W|Thompson JS|Doncals DE|Cantuaria GHC|D'Souza DP|Chang A|Kundapur V|Mohan DS|Haas ML|Kim YB|Ferguson CL|Pugh SL|Kachnic LA|Bruner DW (Ed.), J Clin Oncol, United States, 40(27), 3115-3119.

Editorial

  1. Cruttenden J, Balogun OD, Gaffney D, Suneja G (2024). Destigmatizing gynecologic cancers and prioritizing prospective radiotherapy studies. Gynecol Oncol, 182, 121-123.
  2. Dee EC, Eala MAB, Small W Jr, Gaffney DK, Tangco ED, Abdel-Wahab M, Grover S (2022). Equity in Radiation Oncology Trials: from Knowledge Generation to Clinical Translation. Int J Radiat Oncol Biol Phys, 113(3), 511-512.
  3. Gaffney D, Creutzberg CL, Jhingran A (2022). Special Issue: Radiation Oncology in Gynecologic Malignancies. Int J Gynecol Cancer, 32(3), 215.
  4. Hutten RJ, Huang YJ, Gaffney DK (2021). Stereotactic body radiotherapy for the treatment of gynecologic malignancies: Passing fancy or here to stay? Gynecol Oncol, 161(3), 642-644.

Letter

  1. Mutch D, Gaffney D, Matias-Guiu X, Fotopoulou C, Concin N, Berek JS, FIGO Endometrial Cancer Subcommittee (2024). Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification. [Letter to the editor]. Int J Gynaecol Obstet.
  2. Burt L, Gaffney D (2023). Take Your Best Shot Upfront! [Letter to the editor]. Int J Radiat Oncol Biol Phys, 118(2), 319-320.
  3. Concin N, Matias-Guiu X, Fotopoulou C, Creutzberg C, Mutch D, Gaffney D, Lindemann K, Kehoe S, Berek JS, FIGO Committee on Womens Cancer (2023). Response: FIGO staging of endometrial cancer 2023. [Letter to the editor]. Int J Gynaecol Obstet, 164(1), 369-372.
  4. Mileshkin LR, Narayan K, Gaffney DK, Barnes EH, Lee YC, Monk BJ, Stockler MR (2023). Adjuvant chemotherapy for locally advanced cervical cancer - Authors' reply. [Letter to the editor]. Lancet Oncol, 24(7), e290.
  5. Laggis CWLamb ASecrest AMUfkes NHalwani ASTao RGaffney DMiles RRFlorell SRWada D (2021). Favourable outcomes in folliculotropic mycosis fungoides after multimodality treatment in a single institution [Letter to the editor]. J Eur Acad Dermatol Venereol, 35(1), e42-e45.

Other

  1. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM (2024). Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913. Eur J Cancer (202, p. 114017). England.
  2. Casper AC, Parsons MW, Chipman J, Burt LM Jr, Suneja G, Maurer KA, Gaffney DK (2021). Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up. Gynecol Oncol (162(2), pp. 454-460). United States.

Video/Film/CD/Web/Podcast

  1. Gaffney DK (). Commentary on GROINSS VII [Podcast]. Journal of Clinical Oncology: American Society for Radiation Oncology.
  2. Gaffney DK (). Multidisciplinary Conversations with Radiation Oncologist David Gaffney, International Gynecologic Cancer Society (IGCS) [Web]. Available: https://youtu.be/No46vquyajA?si=8rt46MGOQVxkP8ze.